Parkinsons Vs Multiple Sclerosis: How Are These Conditions Different
Parkinson’s Disease and Multiple Sclerosis are two medical conditions that are frequently confused with each other since they are both progressive and have similar symptoms, but there are some significant differences between the two.
Here we will discuss the difference and similarities between the two.
Specific Instruction That Will Enhance Your Understanding And Ability To Deliver Better Patient Care
- Top neurologists specializing in Multiple Sclerosis share information concerning the results from current research and clinical studies for patients with Multiple Sclerosis
- Evidence-based research enables the clinician to understand the underlying mechanism of this disease process, diagnostic tools currently being utilized, medications and the importance of therapy, and the future of MS treatments
Parkinsons Disease Vs Multiple Sclerosis: Differences
Some of the differences between Parkinsons disease and multiple sclerosis include:
- Parkinson’s symptoms usually appear at the age of 60 and beyond, whereas multiple sclerosis commonly affects individuals between the age group of 20 and 50.
- According to several research, having multiple sclerosis may increase your chance of developing Parkinsons disease later in life. This is due to inflammation caused by multiple sclerosis, which can cause lesions in the brain, affecting how dopamine is produced. However, the reverse has yet to be confirmed.
- Parkinson’s disease develops when the brain generates tiny levels of dopamine, a hormone that regulates movement, whereas multiple sclerosis is an autoimmune illness in which the immune system attacks and destroys the myelin sheath around nerve axons.
- Parkinson’s disease involves a few unique symptoms, such as foot-dragging, slowness of movement , poor posture, lack of control over motions such as blinking or smiling, and others. Dizziness, double vision, tingling feelings throughout the body, hearing loss, and seizures.
You May Like: Fitflop Shoes For Parkinson’s
Emotional Changes In Multiple Sclerosis And Parkinsons Disease
Rao, S.M., Huber, S.J., & Bornstein, R.A. Emotional changes in multiple sclerosis and Parkinsons disease, 60 , 369-378
Patients with MS or PD exhibit a higher prevalence of emotional disorders relative to other patient groups with comparable degrees of physical disability. This article examines specific methodological issues associated with research in this area, describes the range and severity of emotional disorders in MS and PD, and examines both endogenous and reactive explanations to account for the increased prevalence of emotional dysfunction in these two disorders.
What Is Parkinsons Disease
Parkinsons disease is a neurodegenerative disorder that affects predominately dopamine-producing neurons in a specific area of the brain called substantia nigra. Dopamine is a neurotransmitter that is primarily responsible for controlling movement, emotional responses and the ability to feel pleasure and pain.
The cells that make dopamine are impaired and as the disease progresses, the more dopamine-producing brain cells die. Once a person develops motor symptoms, the amount of dopamine loss is already substantial. The brain eventually reaches a point where it stops producing dopamine in any significant amount, thus increasing problems with movement.
Don’t Miss: Pfnca Wellness Programs
Ethics Approval And Consent To Participate
The study was carried out in accordance with the recommendations of the Oregon Health & Science University institutional review board with written informed consent from all subjects. All subjects gave written informed consent in accordance with the Declaration of Helsinki. The protocols were approved by the OHSU IRB .
Also Check: Diseases Similar To Parkinsons
Classification Of The Neurological Disorder Based On Oculomotor Abnormalities
Figure 4. Results of STP-based clustering analysis for the entire tested population. Principle Component Analysis : all the spatio-temporal features available from SONDA were used as an input for the PCA. The resulting components were processed with t-SNE to represent the high-dimensionality dataset into a lower-dimensionality space for clustering purposes. Computation of the optimal number of clusters using the elbow method with the Within-clusters Sum of Squares as a parameter. Result of the k-means clustering algorithm applied to the outcome components of t-SNE.
Also Check: Voice Amplifiers For Parkinson’s
What Are Treatments For Symptoms Of Ms Vs Als
Treatments for ALS cannot reverse the nerve damage, but they can only slow progression of disease. The US FDA has approved two drugs for the treatment of ALS-riluzole and edaravone .
MS treatment is not a cure for multiple sclerosis. Treatments may help speed recovery from an MS exacerbation of symptoms and may slow the progression of the disease. Although a few patients may have mild symptoms, and not require treatment. Treatments for MS attacks can include corticosteroids and plasma exchange . For progressive recurrent MS, ocrelizumab is the only FDA-approved therapy. There are a number of other drugs for relapsing-remitting MS that may be prescribed by a neurologist to help reduce symptoms.
Treatment protocols for ALS and MS are best determined by your individual situation. Treatments are best determined in consultation with your primary care physician and a consultant such as a neurologist.
Diagnostic Blood Tests Can Cause Confusion
Diagnostic blood tests, recommended by the Centers for Disease Control , are analyzed for B. burgdorferi-specific antibodies, commonly thought of as the most important tool for the diagnosis of Lyme exposure. The test can, therefore, come back with negative results if the tick bite was less than a month before because it can take weeks for the body to develop an immune response which would produce positive test results. A clearer path to Lyme diagnosis occurs when there is a classic bulls-eye rash, but the rash doesnt develop or is not visible in all cases.2,3 The most common route when neither MS nor Lyme can be definitively diagnosed is to closely monitor the patient over time to see if there is progression or difference in test results.
Don’t Miss: Zhichan Capsule
Is There A Cure For Parkinsons
Theres currently no cure for Parkinsons, a disease that is chronic and worsens over time. More than 50,000 new cases are reported in the United States each year. But there may be even more, since Parkinsons is often misdiagnosed.
Its reported that Parkinsons complications was the
Complications from Parkinsons can greatly reduce quality of life and prognosis. For example, individuals with Parkinsons can experience dangerous falls, as well as blood clots in the lungs and legs. These complications can be fatal.
Proper treatment improves your prognosis, and it increases life expectancy.
It may not be possible to slow the progression of Parkinsons, but you can work to overcome the obstacles and complications to have a better quality of life for as long as possible.
Parkinsons disease is not fatal. However, Parkinsons-related complications can shorten the lifespan of people diagnosed with the disease.
Having Parkinsons increases a persons risk for potentially life threatening complications, like experiencing:
- falls
Parkinsons often causes problems with daily activities. But very simple exercises and stretches may help you move around and walk more safely.
Multiple Sclerosis And Parkinsons Tissue Bank
Providing high quality human tissue for vital research
The Multiple Sclerosis and Parkinsons Tissue Bank is a national collection of central nervous system tissue samples donated by individuals with multiple sclerosis , Parkinsons disease and related neuroinflammatory and neurodegenerative conditions.
The vision of the Tissue Bank is one that it shares with its funding charities, the Multiple Sclerosis Society and Parkinsons UK that we can live in a world where the cause of these debilitating neurological conditions has been discovered, and an intervention identified that stops them from developing in susceptible individuals or stops further progression of the condition.
The Tissue Banks mission is to facilitate these discoveries by making well-characterised human material of the highest quality readily available to the research community engaged in studies aimed at discovering the cause and better treatments for multiple sclerosis and Parkinsons disease. Furthermore, we aim to encourage the greater use of the material in these studies. It is by carrying out this work that the Tissue Bank fulfils the last, generous and selfless wishes of all those who have registered on the donor scheme and bequeathed their CNS tissues to research.
Don’t Miss: Does Vitamin B12 Help Parkinson’s
Parkinsons Disease: Possible Mechanisms For Nutritional Approaches
Parkinsons disease is among the most common chronic neurodegenerative conditions, affecting 1% of those over 60 years of age, and involves motor and non-motor impairments. Thus, better clinical outcomes may result when practitioners utilize nutritional and supplement interventions that support reductions in neuroinflammation and neurodegeneration as early as possible.
How Effective Is Early Treatment Of Ms And Parkinsons
Though not a cure, nipping neurologic disorders in the bud may help slow their progression. But proper diagnosis is necessaryand thats not easy.
Arlie Barber knew something was wrong when, in the spring of 2008, she found herself running to the bathroom all the time. Her gynecologist diagnosed her with overactive bladder. But Barber, then 35, was an avid runner who had never had children. The diagnosis didn’t seem to fit.
ILLUSTRATION BY BRIAN STAUFFER
A few months later, she woke up with half her face numb. Her doctor blamed it on the Botox injection Barber had received a few days earlier, but the numbness spread over the next few weeks to her hands and feet. Along with balance problems and a sense of just not “feeling right,” Barber knew something was amiss. But it wasn’t until she described her symptoms to a second doctor in October 2008 that she started to get answers that made sense. “When a woman your age describes symptoms like these,” the doctor told her, “the medical community thinks .”
Given Barber’s symptoms and lesions, the doctor strongly suspected Barber would eventually be diagnosed with MS, so he offered to start her on treatment. But many of the drugs used to treat the condition require injections and can have significant side effects. “He told me that it was really serious stuff and to be really sure that’s what I wanted to do,” she says.
Early Treatment in Multiple Sclerosis
Early Treatment for Parkinson’s Disease
You May Like: On-off Phenomenon
Common Misdiagnosis: Peripheral Neuropathy
Peripheral neuropathy occurs when the nerves outside of the brain and spinal cord are damaged. Muscle contractions are a common physical symptom. In contrast, PD has a variety of physical, mental, and emotional symptoms.
My husband started tremors 14 years ago but was only diagnosed last year. The doctor had previously said it was peripheral neuropathy.
My old neurologist for 11 years said peripheral neuropathy! VA then said 50/50 Parkinsons and sent me to the CU Movement Disorder Center. My new neurologist watched me walk along with other tests and said Parkinsons.
Combination Of Stp With Statistical And Dynamic Properties Of Saccades
Next, we explored whether taking into account the frequency distribution of saccades and their dynamic properties as a function of direction in combination with STP obtained from the saccadic pursuit condition, would allow for a better characterization of the oculomotor disorders. The results for the left and right eye are displayed separately.
Figures 5, 6 show the results for MS and PD groups, respectively. At a group level, MS patients showed impaired STP , no significant difference in the saccadic frequency distribution and significantly different amplitude and velocity , primarily along the horizontal axis. Still at the group level, PD patients showed impaired STP , significantly reduced saccadic frequency along the vertical axis , and significantly different amplitude and velocity . Overall the PD group showed more significant deviations from controls compared to the MS group.
Figure 5. MS and PD group analysis of normalized spatio-temporal properties. Normalized saccadic frequency distribution as a function of direction. Normalized saccadic amplitude as a function of direction. Normalized saccadic peak velocity as a function of direction. The results of the saccadic dynamics are stratified per quartile. An asterisk indicates a significant difference between normative values obtained from the control group.
Figure 6. Same as Figure 5.
Figure 8. Same as Figure 7.
Read Also: Sam Waterston Parkinson’s
Restless Legs Syndrome And Periodic Limb Movement Disorder
Most people who have RLS also have a condition called periodic limb movement disorder . PLMD involves repetitive flexing or twitching of the limbs while asleep at night. It is different from RLS in that these movements are not accompanied by uncomfortable sensations and because they occur during sleep, patients are often not aware of them. However, PLMD-associated movements can cause a person to wake up and therefore can compound sleep issues in patients who also have RLS.
Although most people with RLS have PLMD, many with PLMD do not have RLS.
Your Dreams Could Be An Early Clue To Parkinsons Disease
Actor Alan Alda revealed that he has Parkinsons disease and in an interview Tuesday on CBS This Morning, the award-winning actor said an unusual dream helped lead to his diagnosis.
Alda, best known for his portrayal of Army Capt. Hawkeye Pierce in the TV series M*A*S*H, was diagnosed three and a half years ago after experiencing a lesser-known early sign of Parkinsons. He said he asked his doctor to test him for the disease after reading an article about how physically acting out your dreams can be one of the earliest precursors of the neurological disorder.
Restless Legs Syndrome: A Common Underdiagnosed Disorder
US Pharm.
Neurological Conditions: Ms Parkinsons Disease Als
Neurological conditions like MS, Parkinsons and ALS can all, more or less, cause reduced ability to use the faces and mouths functions like being able to eat, chew, swallow, speak and smile.
In this section we briefly describe MS, Parkinsons, ALS and the usual symptoms for their diagnosis. MS, Parkinsons and ALS differ symptom-wise but have similar problems and requirements for treatment.
Later, we will show how exercise with IQoro can function as a complement to traditional physiotherapy to maintain the health of the bodys, faces and mouths functions as long as possible. IQoro is a new and unique neuromuscular treatment method that requires just 30 seconds exercise, three times per day.
Neurological sicknesses affect the central nervous system: both the brain and the spine and also those nerves out in the body the peripheral nerve system which sends, for example, signals to and from our fingers and the central nervous system.
Also affected are those nerves that control our inner organs, the autonomic nerve system, which cannot be controlled voluntarily. In summary, all of these nerve systems can be affected to different degrees depending upon which neurological condition is present.
In all of these neurological sickness groups there will exist symptoms of dysphagia, eating-, chewing- and swallowing difficulties to different degrees depending upon the exact condition and its severity.
Recommended Reading: What Foods Should Be Avoided When Taking Levodopa
What Is Multiple Sclerosis
Multiple sclerosis is a progressive and debilitating disease of the central nervous system that disables the communication between the brain and other parts of the body. It involves an immune-mediated process in which an abnormal response of the bodys immune system is directed against the central nervous system.
Within the central nervous system , the immune system causes inflammation that damages myelinthe fatty substance that surrounds and insulates the nerve fibersas well as the nerve fibers themselves, and even the specialized cells that make myelin. When the nerve fibers are destroyed, messages within the CNS are altered or halted completely. Then, the damaged areas produce neurological symptoms that can vary among people in type and severity. These areas develop scar tissue, giving the disease its namemultiple areas of scarring or multiple sclerosis.
Rehab Clinical Tools Instructed In This Parkinsons And Ms Rehab Course To Enhance Your Functional Outcomes
- Evidence-based tools and measurement scales optimize the efficiency for proper assessment and treatment of Parkinsons and Multiple Sclerosis
- Rehab techniques demonstrate how to improve the energy efficiency of these patients while promoting functional movement
- Demonstrations of how to incorporate Tai Chi, Pilates, and Boxing into a comprehensive rehab program to increase a neurologically involved patients gait, coordination, strength, balance, and overall quality of life
Don’t Miss: Similar To Parkinsons
Is There A Link
Some people have MS and Parkinsonâs, but it could be a coincidence.
Research suggests that the damage that MS causes to your brain can lead some people to develop Parkinsonâs later on.
If you have MS, your immune system triggers ongoing inflammation. This can create lesions in your brain that cause Parkinsonâs disease. If lesions form in certain spots in your brain, they can affect how it makes dopamine.
Gait In People With Pd
Slow gait speed and small foot strike angle were significantly different daily life gait measures in the PD group compared to the PD-Ctl group. Previous studies of gait in daily life agree that foot strike angle , and gait speed discriminated gait in PD from healthy control groups. Surprisingly, none of the laboratory gait measures discriminated gait characteristics in mild-moderate PD , from the PD-Ctl group, after Bonferronis correction, suggesting that monitoring gait during daily life is more sensitive to impairments from PD than gait test in the laboratory. The participants with PD showed much larger changes in their gait parameters between the laboratory and daily life than the controls or people with MS. This difference in performance in a laboratory test and daily life in people with PD may be due to their reliance on less automatic, more attention demanding gait mechanisms that would make gait in daily life more challenging . The difference could also be due to people with PD being more prone to placebo effects and white coat effects than the other groups, so they perform better when their performance is observed. Alternatively, it might be that we picked up the ON and OFF fluctuations during daily life that influenced the averaged gait measures over a week. Nevertheless, assessing mobility during daily life resulted in more sensitive and specific differences in gait characteristics than laboratory gait between the PD and control groups.
You May Like: Parkinson’s Double Vision